Prognostic impact and immunotherapeutic implications of NETosis-related prognostic model in clear cell renal cell carcinoma
Open Access
- 27 May 2024
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 150 (5) , 278
Abstract
Background: The ramifications of necroptosis on the prognostication of clear cell renal cell carcinoma (ccRCC) remain inadequately expounded. Methods: A prognostic model delineating the facets of necroptosis in ccRCC was constructed, employing a compendium of algorithms. External validation was effectuated using the E-MTAB-1980 dataset. The exploration of immune infiltration scores was undertaken through the exploitation of multiple algorithms. Single-cell RNA sequencing data were procured from the GSE171306 dataset. Real-time quantitative PCR (RT-qPCR) was engaged to scrutinize the differential expression of SLC25A37 across cancer and paracancer tissues, as well as diverse cell lines. Assessments of proliferative and metastatic alterations in 769-P and 786-O cells were accomplished through Cell Counting Kit-8 (CCK8) and wound healing assays. Results: The necroptosis-related signature (NRS) emerges as a discerning metric, delineating patients’ immune attributes, tumor mutation burden, immunotherapy response, and drug susceptibility. Single-cell RNA sequencing analysis unveils the marked enrichment of SLC25A37 in tumor cells. Concurrently, RT-qPCR discloses the overexpression of SLC25A37 in both ccRCC tissues and cell lines. SLC25A37 knockdown mitigates the proliferative and metastatic propensities of 769-P and 786-O cells, as evidenced by CCK8 and wound healing assays. Conclusion: The NRS assumes a pivotal role in ascertaining the prognosis, tumor mutation burden, immunotherapy response, drug susceptibility, and immune cell infiltration features of ccRCC patients. SLC25A37 emerges as a putative player in immunosuppressive microenvironments, thereby providing a prospective avenue for the design of innovative immunotherapeutic targets for ccRCC.Keywords
All Related Versions
Funding Information
- Young Scholars Fostering Fund of the First Affiliated Hospital of Nanjing Medical University (PY2022052)
- Nanjing Study Abroad Returnees (BSHNJ200208(JD22))
This publication has 56 references indexed in Scilit:
- Neutrophil extracellular traps in immunity and diseaseNature Reviews Immunology, 2017
- Treatment of renal cell carcinoma: Current status and future directionsCA: A Cancer Journal for Clinicians, 2017
- Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinomaUrologic Oncology: Seminars and Original Investigations, 2017
- Identification of SLC25A37 as a major depressive disorder risk geneJournal of Psychiatric Research, 2016
- miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunctionJournal of Translational Medicine, 2016
- Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapyAnnals of Oncology, 2016
- SLC transporters as therapeutic targets: emerging opportunitiesNature Reviews Drug Discovery, 2015
- Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinomaOncotarget, 2015
- Mitochondrial uncoupling protein 2 expression in colon cancer and its clinical significanceWorld Journal of Gastroenterology, 2010
- Expression of Uncoupling Protein-2 in Human Colon CancerClinical Cancer Research, 2004